The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Megestrol acetate for treatment of anorexia-cachexia syndrome
Open accessAbstract
BACKGROUND: This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia-cachexia syndrome'. Megestrol acetate (MA) is currently used to improve appetite and to increase weight in cancer-associated anorexia. In 1993, MA was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia or unexplained weight loss in patients with AIDS. The mechanism by which MA increases appetite is unknown and its effectiveness for anorexia and cachexia in neoplastic and AIDS (acquired immunodeficiency syndrome) patients is under investigation. OBJECTIVES: To evaluate the efficacy, effectiveness and safety of MA in palliating anorexia-cachexia syndrome in patients with cancer, AIDS and other underlying pathologies. SEARCH METHODS: We sought studies through an extensive search of electronic databases, journals, reference lists, contact with investigators and other search strategies outlined in the methods. The most recent search for this update was carried out in May 2012. SELECTION CRITERIA: Studies were included in the review if they assessed MA compared to placebo or other drug treatments in randomised controlled trials of patients with a clinical diagnosis of anorexia-cachexia syndrome related to cancer, AIDS or any other underlying pathology. DATA COLLECTION AND ANALYSIS: Two independent review authors conducted data extraction and evaluated methodological quality. We performed quantitative analyses using appetite and quality of life as a dichotomous variable, and analysed weight gain as continuous and dichotomous variables. MAIN RESULTS: We included 35 trials in this update, the same number but not the same trials as in the previous version of the review. The trials comprised 3963 patients for effectiveness and 3180 for safety. Sixteen trials compared MA at different doses with placebo, seven trials compared different doses of MA with other drug treatments and 10 trials compared different doses of MA. Meta-analysis showed a benefit of MA compared with placebo, particularly with regard to appetite improvement and weight gain in cancer, AIDS and other underlying conditions, and lack of benefit in the same patients when MA was compared to other drugs. There was insufficient information to define the optimal dose of MA, but higher doses were more related to weight improvement than lower doses. Quality of life improvement in patients was seen only when comparing MA versus placebo but not other drugs in both subcategories: cancer and AIDS. Oedema, thromboembolic phenomena and deaths were more frequent in the patients treated with MA. More than 40 side effects were studied. AUTHORS' CONCLUSIONS: This review shows that MA improves appetite and is associated with slight weight gain in cancer, AIDS and in patients with other underlying pathology. Despite the fact that these patients are receiving palliative care they should be informed of the risks involved in taking MA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Chapter 9: Analysing Data and Undertaking Meta-Analyses
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008) · Cited by 2,782
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Verso, M., & Agnelli, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.008 · Cited by 605
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
Inui, A. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.2.72 · Cited by 579
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559
Fossati, R., Confalonieri, C., Torri, V, Ghislandi, E., Penna, A., Pistotti, V, Tinazzi, A., & Liberati, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3439 · Cited by 546
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].
Boissel, J., Cucherat, M., Li, W., Châtellier, G., Gueyffier, F., Buyse, M. E., Boutitie, F., Nony, P., Haugh, M., & Mignot, G. (1999) · PubMed · Cited by 533
Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J., & Fearon, K. C. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690654 · Cited by 459
Cardiac cachexia: A systematic overview
von Haehling, S., Lainscak, M., Springer, J., & Anker, S. D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.009 · Cited by 348
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., Krook, J. E., Wilwerding, M. B., Rowland, K. M., Camoriano, J. K., Novotny, P. J., & Christensen, B. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3299 · Cited by 343
Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
Loprinzi, C. L., Ellison, N. M., Schaid, D. J., Krook, J. E., Athmann, L. M., Dose, A. M., Mailliard, J. A., Johnson, P. S., Ebbert, L. P., & Geeraerts, L. H. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1127 · Cited by 318
Megestrol Acetate in Patients with AIDS-related Cachexia
Von Roenn, J. H., Armstrong, D., Kotler, D. P., Cohn, D. L., Klimas, N. G., Tchekmedyian, N. S., Cone, L., Brennan, P. J., & Weitzman, S. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-6-199409150-00001 · Cited by 296
Jatoi, A., Rowland, K., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., MacDonald, N., Gagnon, B., Novotny, P. J., Mailliard, J. A., Bushey, T. I. L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.024 · Cited by 296
Mangili, A., Murman, D. H., Zampini, A. M., Wanke, C. A., & Mayer, K. H. (2006) · Clinical Infectious Diseases · doi:10.1086/500398 · Cited by 270
The cancer anorexia-cachexia syndrome.
Nelson, K. A., Walsh, D., & Sheehan, F. A. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.213 · Cited by 265
Systematic Review of the Treatment of Cancer-Associated Anorexia and Weight Loss
Yavuzsen, T., Davis, M. P., Walsh, D., LeGrand, S., & Lagman, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8010 · Cited by 240
Mantovani, G., Macciò, A., Madeddu, C., Serpe, R., Massa, E., Dessì, M., Panzone, F., & Contu, P. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0153 · Cited by 231
Body-composition changes in patients who gain weight while receiving megestrol acetate.
Loprinzi, C. L., Schaid, D. J., Dose, A. M., Burnham, N. L., & Jensen, M. D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.152 · Cited by 230
Loprinzi, C. L., Michalak, J. C., Schaid, D. J., Mailliard, J. A., Athmann, L. M., Goldberg, R. M., Tschetter, L. K., Hatfield, A. K., & Morton, R. F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.762 · Cited by 223
Megestrol acetate for treatment of anorexia-cachexia syndrome
Berenstein, G., & Ortiz, Z. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004310.pub2 · Cited by 206
Wigmore, S. J., Fearon, K. C. H., Maingay, J. P., & Ross, J. A. (1997) · Clinical Science · doi:10.1042/cs0920215 · Cited by 195
Nutritional and Anti-Inflammatory Interventions in Chronic Heart Failure
Kalantar-Zadeh, K., Anker, S. D., Horwich, T. B., & Fonarow, G. C. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.03.007 · Cited by 193
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients
Wolf, I., Sadetzki, S., Kanety, H., Kundel, Y., Pariente, C., Epstein, N., Oberman, B., Catane, R., Kaufman, B., & Shimon, I. (2006) · Cancer · doi:10.1002/cncr.21690 · Cited by 184
Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome
Pascual López, A., Roqué i Figuls, M., Urrútia Cuchi, G., Graciela Berenstein, E., Almenar Pasies, B., Balcells Alegre, M., & Herdman, M. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.09.007 · Cited by 184
McMillan, D. C., Wigmore, S. J., Wigmore, K. C. H., O’Gorman, P., Wright, C. E., & McArdle, C. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690077 · Cited by 174
Megestrol Acetate in Patients with AIDS and Cachexia
Oster, M. H., Enders, S. R., Samuels, S. J., Cone, L. A., Hooton, T. M., Browder, H. P., & Flynn, N. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-6-199409150-00002 · Cited by 171
Managing Cancer-Related Anorexia/Cachexia
Mantovani, G., Macci??, A., Massa, E., & Madeddu, C. (2001) · Drugs · doi:10.2165/00003495-200161040-00004 · Cited by 168
Megestrol acetate in cancer anorexia and weight loss
Tchekmedyian, N. S., Hickman, M., Siau, J., Greco, F. A., Keller, J. W., Browder, H. P., & Aisner, J. (1992) · Cancer · doi:10.1002/cncr.2820690532 · Cited by 153
Madeddu, C., Dessì, M., Panzone, F., Serpe, R., Antoni, G., Cau, M. C., Montaldo, L., Mela, Q., Mura, M., Astara, G., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.10.005 · Cited by 153
Anorexia in hemodialysis patients: An update
Bossola, M., Tazza, L., Giungi, S., & Luciani, G. (2006) · Kidney International · doi:10.1038/sj.ki.5001572 · Cited by 148
Maltoni, M. C., Nanni, O., Scarpi, E., Rossi, D., Serra, P., & Amadori, D. (2001) · Annals of Oncology · doi:10.1023/a:1011156811739 · Cited by 147
Yeh, S., Wu, S., Lee, T., Olson, J. S., Stevens, M. R., Dixon, T. E., & Schuster, M. W. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04993.x · Cited by 142
Timpone, J. G., Wright, D. J., Li, N., Egorin, M. J., Enama, M. E., Mayers, J., Galetto, G., & DATRI 004 STUDY GROUP (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.305 · Cited by 133
Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review
Garg, S., Yoo, J. J., & Winquist, E. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0686-3 · Cited by 119
Oral Feeding Options for Patients with Dementia: A Systematic Review
Hanson, L., Ersek, M., Gilliam, R., & Carey, T. (2011) · Journal of The American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03320.x · Cited by 117
Nutritional interventions for cancer-induced cachexia
Gullett, N. P., Mazurak, V. C., Hebbar, G., & Ziegler, T. R. (2011) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2011.01.001 · Cited by 114
Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment
Kumar, N. B., Kazi, A., Smith, T., Crocker, T., Yu, D., Reich, R. R., Reddy, K. A., Hastings, S., Extermann, M., Balducci, L., et al. (2010) · Current Treatment Options in Oncology · doi:10.1007/s11864-010-0127-z · Cited by 114
Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD Patients
Weisberg, J. I., Wanger, J. S., Olson, J. S., Streit, B., Fogarty, C. M., Martin, T. J., & Casaburi, R. H. (2002) · CHEST Journal · doi:10.1378/chest.121.4.1070 · Cited by 108
Usefulness of Megestrol Acetate in Cancer Cachexia and Anorexia
Feliú, J., González‐Barón, M., Berrocal, A., Artal, A., Ordóñez, A., Garrido, P., Zamora, P. L., de Paredes, M. L. G., & Montero, J. M. (1992) · American Journal of Clinical Oncology · doi:10.1097/00000421-199210000-00008 · Cited by 108
Mantovani, G., Macciò, A., Lai, P., Massa, E., Ghiani, M., & Santona, M. C. (1998) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v9.i2.10 · Cited by 106
Fearon, K. C. H., & Moses, A. G. W. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00235-8 · Cited by 103
Mantovani, G., Macciò, A., Madeddu, C., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.12.010 · Cited by 101
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial.
Navari, R. M., & Brenner, M. C. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0739-7 · Cited by 99
Bruera, E. D., Ernst, S., Hagen, N. A., Spachynski, K., Belzile, M., Hanson, J., Summers, N., Brown, B. A., Dulude, H., & Gallant, G. (1998) · PubMed · Cited by 99
Reuben, D. B., Hirsch, S. H., Zhou, K., & Greendale, G. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53307.x · Cited by 98
Pharmacologic Treatment of Cancer-Related Fatigue
Carroll, J. K., Kohli, S., Mustian, K. M., Roscoe, J. A., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-43 · Cited by 98
Conno, F. D., Martini, C., Zecca, E., Balzarini, A., Venturino, P., Groff, L., & Caraceni, A. T. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00219-6 · Cited by 93
Sullivan, D. H., Roberson, P. K., Smith, E. S., Price, J. A., & Bopp, M. M. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.01010.x · Cited by 87
HIV-Related Wasting in HIV-Infected Drug Users in the Era of Highly Active Antiretroviral Therapy
Campa, A. L., Zhifang, Y., Lai, S., Xue, L., Phillips, J. C., Sales, S., Page, J. B., & Baum, M. K. (2005) · Clinical Infectious Diseases · doi:10.1086/444499 · Cited by 86
Yeh, S., Wu, S.-Y., Levine, D. M., Parker, T. S., Olson, J., Stevens, M. R., & Schuster, M. W. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.1.m48 · Cited by 79
Cancer cachexia: A therapeutic approach
Argilés, J. M. A., Meijsing, S. H., Pallarés‐Trujillo, J., Guirao, X., & López-Soriano, F. J. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200101)21:1<83::aid-med4>3.0.co;2-1 · Cited by 78
Hellerstein, M. K., Kahn, J. S., Mudie, H., & Viteri, F. E. (1990) · PubMed · Cited by 78
Tang, A., Jacobson, D. L., Spiegelman, D. L., Knox, T. A., & WANKE, C. A. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000159627.54149.2e · Cited by 76
Optimal management of cancer anorexia–cachexia syndrome
Argiles, J. M., Oliván, M., Busquets, S., López-Soriano, F. J., & Argiles, J. M. (2010) · Cancer Management and Research · doi:10.2147/cmar.s7101 · Cited by 75
Muss, H. B., Case, L. D., Capizzi, R. L., Cooper, M. R., Cruz, J. M., Jackson, D. V., Richards, F., Powell, B. L., Spurr, C. L., & White, D. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1797 · Cited by 73
Clinical Management of Anorexia and Cachexia in Patients with Advanced Cancer
Bruera, E. D. (2009) · Oncology · doi:10.1159/000227126 · Cited by 72
Medications Associated with Weight Gain
Malone, M. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g333 · Cited by 72
Novel approaches to the treatment of cachexia
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.008 · Cited by 71
Leśniak, W., Bała, M. M., Jaeschke, R., & Krzakowski, M. J. (2008) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.510 · Cited by 67
Ross, D. D., & Alexander, C. S. (2001) · PubMed · Cited by 66
Westman, G., Bergman, B., Albertsson, M., Kadar, L., Gustavsson, G., Thaning, L., Andersson, M. V., Straumits, A., Jeppsson, B. W., Lindén, C. J., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00398-0 · Cited by 61
Marchand, V., Baker, S. S., Stark, T. J., & Baker, R. D. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2000.tb07114.x · Cited by 60
Pharmacological Treatment of Geriatric Cachexia: Evidence and Safety in Perspective
Yeh, S., Lovitt, S., & Schuster, M. W. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.05.001 · Cited by 59
Orexigenic and anabolic agents
Morley, J. E. (2002) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00036-8 · Cited by 59
Megestrol acetate in cachexia and anorexia
Yeh, S., & Schuster, M. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.411 · Cited by 57
Treating malnutrition with megestrol acetate: literature review and review of our experience.
Karcic, E., Philpot, C. D., & Je, M. (2002) · PubMed · Cited by 52
Tisdale, M. J. (1993) · Anti-Cancer Drugs · doi:10.1097/00001813-199304000-00001 · Cited by 52
Estimating rates of change in randomized clinical trials
Laird, N. M., & Wang, F. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90018-w · Cited by 47
Mechanisms and Treatment of Anorexia in End-Stage Renal Disease Patients on Hemodialysis
Bossola, M., Tazza, L., & Luciani, G. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.003 · Cited by 47
Megestrol Acetate and Mirtazapine for the Treatment of Unplanned Weight Loss in the Elderly
Fox, C. B., Treadway, A. K., Blaszczyk, A. T., & Sleeper, R. B. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.4.383 · Cited by 43
Treatment of cancer anorexia with megestrol acetate: impact on quality of life.
Tchekmedyian, N. S., Hickman, M. A., Siau, J., et al. (1990) · PubMed · Cited by 43
Clinical Anticachexia Treatments
Tisdale, M. J. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021002168 · Cited by 41
Simmons, S. F., Walker, K. A., & Osterweil, D. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.03.014 · Cited by 40
Tchekmedyian, N. S., Hickman, M. A., & Heber, D. (1991) · PubMed · Cited by 39
Studies of high-dose megestrol acetate: potential applications in cachexia.
Aisner, J., Tchekmedyian, N. S., Tait, N. S., et al. (1988) · PubMed · Cited by 37
Anorexia in end-stage renal disease: pathophysiology and treatment
Álvarez, V., Diéz, J. J., Aguilera, A., Selgas, R., Codoceo, R., & Bajo, M. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.11.1825 · Cited by 36
HIV Wasting Syndrome: Treatment Update
Balog, D. L., Epstein, M. E., & Amodio-Groton, M. I. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17072 · Cited by 36
Yeh, S., Marandi, M., Thode, H. C., Levine, D. M., Parker, T. S., Dixon, T. E., & Schuster, M. W. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2009.08.005 · Cited by 35
Mulligan, K. M., Zackin, R. A., Roenn, J. H. V., Chesney, M. A., Egorin, M. J., Sattler, F. R., Benson, C. A., Liu, T., Umbleja, T., Shriver, S., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0954 · Cited by 35
Cruz, J. M., Muss, H. B., Brockschmidt, J. K., & Evans, G. W. (1990) · PubMed · Cited by 35
Pharmacological options for advanced cancer patients with loss of appetite and weight
Behl, D., & Jatoi, A. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1085 · Cited by 34
Yeh, S., Hafner, A., Chang, C., Levine, D. M., Parker, T. S., & Schuster, M. W. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52465.x · Cited by 32
García, V. R., Juan, Ó., Pérez‐Hoyos, S., Peiró, R., Ramón, N., Rosero, M. Á., & García, M. Á. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)73352-6 · Cited by 32
USAGE of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly
Yeh, S., Lovitt, S., & Schuster, M. W. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0082-1 · Cited by 29
Guidelines for the Use of Orexigenic Drugs in Long‐Term Care
Thomas, D. R. (2006) · Nutrition in Clinical Practice · doi:10.1177/011542650602100182 · Cited by 28
Mwamburi, D. M., Gerrior, J., Wilson, I. B., Chang, H., Scully, E., Saboori, S., Miller, L. G., Forfia, J., Albrecht, M., & WANKE, C. A. (2004) · Clinical Infectious Diseases · doi:10.1086/381977 · Cited by 26
A Multidisciplinary Approach to the Management of Breast Cancer, Part 2: Therapeutic Considerations
Pruthi, S., Boughey, J. C., Brandt, K. R., Degnim, A. C., Dy, G. K., Goetz, M. P., Perez, E. A., Reynolds, C. A., Schomberg, P. J., & Ingle, J. N. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1131 · Cited by 26
Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients
Mateen, F. J., & Jatoi, A. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.05.009 · Cited by 26
Megestrol Acetate for Anorexia and Cachexia
Loprinzi, C. L., JOHNSON, P. A., & Jensen, M. (2009) · Oncology · doi:10.1159/000227128 · Cited by 25
Management of cancer anorexia/cachexia
Loprinzi, C. L. (1995) · Supportive Care in Cancer · doi:10.1007/bf00365851 · Cited by 23
Ulutin, H. C., Arpacı, F., & Pak, Y. (2002) · Tumori Journal · doi:10.1177/030089160208800406 · Cited by 20
Treatment of Anorexia With Megestrol Acetate
Tchekmedyian, N. S. (1993) · Nutrition in Clinical Practice · doi:10.1177/0115426593008003115 · Cited by 20
Treatment for HIV wasting syndrome.
Lk, C., & Rl, C. (1994) · PubMed · Cited by 20
Therapeutic strategy for cachexia in chronic kidney disease
MAK, R. H. K., & Cheung, W. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f02204 · Cited by 18
Simmons, S. F., Walker, K. A., & Osterweil, D. (2004) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70040-7 · Cited by 18
Assessment and Management of Gastrointestinal Symptoms in Advanced Illness
McHugh, M. E., & Miller-Saultz, D. (2011) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2011.03.005 · Cited by 13
Nelson, K. A., Walsh, D., & Hussein, M. A. (2002) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910201900313 · Cited by 11
Emerging drugs for cancer cachexia
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.4.555 · Cited by 8
Herrejón, A., Palop, J., Inchaurraga, I., López‐Serrano, A., Bañuls, C., Hernández, A., Blanquer, R., Estañ-Capell, N., & Anguera, A. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.02.016 · Cited by 8
Megestrol Acetate: Promises and Pitfalls
FARRAR, D. J. (1999) · AIDS Patient Care and STDs · doi:10.1089/apc.1999.13.149 · Cited by 7
Chronic pulmonary cachexia syndrome: The role of anorexia
Celık, T., Iyısoy, A., Gündoğdu, F., et al. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.186 · Cited by 4
Treating the anorexia/cachexia syndrome.
Tchekmedyian, N. S. (2006) · PubMed · Cited by 2
Explaining heterogeneity in meta-analysis: a comparison of methods
Thompson, S. G., & Sharp, S. J. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991030)18:20
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
ESPEN practical guideline: Clinical Nutrition in cancer
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Hütterer, E., Isenring, E., Kaasa, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.005 · Cited by 1,702
ESPEN practical guideline: Clinical nutrition in surgery
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., Laviano, A., Ljungqvist, O., Lobo, D. N., Martindale, R. G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.031 · Cited by 1,173
Temel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
Metadata
- Authors
- Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J. L., & Bort-Martí, S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-03-28
- Volume
- 2019
- Issue
- 3
- Pages
- CD004310-CD004310
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2116749750
- Cited by
- 293
- References
- 114
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.